Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Tuesday, 30 November 2021

Psychedelic Stock News: Red Light Holland (CSE: TRIP) (OTC Pink: TRUFF) Reports Second Quarter 2021 Results

Psychedelic Stock News: Red Light Holland (CSE: TRIP) (OTC Pink: TRUFF) Reports Second Quarter 2021 Results

Cannabis Stock News: Nextleaf (CSE: OILS) Announces Glacial Gold to be Available from Coast to Coast

Cannabis Stock News: Nextleaf (CSE: OILS) Announces Glacial Gold to be Available from Coast to Coast

Investor Ideas #Potcasts 614, #Cannabis News and #Stocks on the Move; (TSX: $FAF.TO) (OTCQX: $FFLWF), (TSX: $AVCN.TO) (OTCQX: $AVCNF), (CSE: $LUV.C)

 



Investor Ideas #Potcasts 614, #Cannabis News and #Stocks on the Move; (TSX: $FAF.TO) (OTCQX: $FFLWF), (TSX: $AVCN.TO) (OTCQX: $AVCNF), (CSE: $LUV.C)

 

 

Delta, Kelowna, BC, November 30, 2021 (Investorideas.com Newswire) www.Investoride, as.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/113021-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/11301FAF-AVCN-LUV.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few private and public company announcements.

 

But first, the big news internationally over the last two weeks has been from Germany as the leaders of Germany’s incoming governing parties announced that they have a formal agreement to legalize marijuana and promote broader drug policy harm reduction measures when they take power.

 

“We are introducing the controlled supply of cannabis to adults for consumption in licensed stores,” the parties said in a new 118-page agreement, according to a translation. “This controls the quality [of marijuana], prevents the transfer of contaminated substances and guarantees the protection of minors.”

 

As it stands, personal possession of marijuana is decriminalized in Germany, and there is a medical cannabis program in place. But this proposal seeks to establish a regulated market for adult-use marijuana.

 

The joint government will review the social impact of legalization four years after implementation.

 

Beyond cannabis legalization, the so-called traffic light coalition will also advance other drug policy reforms such as establishing drug-checking services where people can have illicit drugs tested for contaminants and other harmful substances without fear of facing criminal sanctions.

 

The governing coalition—comprised of the Social Democratic Party of Germany (SPD), the Free Democratic Party (FDP) and the Greens—also said that the legislation will restrict advertising for marijuana, alcohol and tobacco products.

 

Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF),  a leading, technology-powered, cannabis retailer announced that, in connection with the potential additional listing of the common shares in the capital of the Company on the Nasdaq, it has filed articles of amendment implementing a consolidation of the Shares on the basis of ten (10) pre-consolidation Shares for every one (1) post-consolidation Share. The Consolidation was previously approved by the Company's shareholders at its annual and special meeting of shareholders held on June 9, 2021.

 

Trevor Fencott, Chief Executive Officer of Fire & Flower commented, "The share consolidation is an important step in our U.S. expansion strategy. It enables Fire & Flower to qualify for a listing on the NASDAQ and expand its shareholder base which, in turn, provides the Company with increased flexibility and enhanced liquidity to accelerate its strategic growth plans."

 

"We have built an industry-leading cannabis consumer technology platform and, as demand for our technology platform continues to build in the U.S., now is the right time to advance our NASDAQ listing and make our shares more accessible to a larger investor audience."

 

"Along with our previously announced acquisitions of trusted cannabis strain information destination, Wikileaf (www.wikileaf.com) and best-in-class dispensary, culture and cannabis marketplace, PotGuide in Denver, Colorado (www.potguide.com), the share consolidation is the next important step in our U.S. expansion strategy. We look forward to completing the listing in the upcoming weeks as we announce continued growth of our cannabis consumer technology platform and execution on our asset-light business model," said Trevor Fencott, CEO of Fire & Flower.

 

Eco Farm Holdings PBC/ Thrive Society, a technology-forward portfolio of operating assets in cannabis cultivation, manufacturing and consumer brands that is unified through a distribution platform and powered by an upstream digital marketplace, announced that its leading distribution platform, which connects cannabis farmers with buyers across the state of California, now supports over 400 cannabis farmers and 200 buyers including distributors, manufacturers, and retailers. The achieved milestone positions Thrive Society as one of the largest data driven, digitally connected supply chains of legal cannabis in the world.

 

Operating in California, one of the largest legal cannabis markets in the world with projected sales reaching $7.2 billion in the state by 2024, Thrive Society is a membership-based cannabis distribution platform with a core mission to deliver a more effective farming life cycle and route-to-market by leveraging Agriculture 4.0 technology and focusing on precision agriculture, the internet of things (IoT) and the use of big data to bring greater efficiencies and visibility to its upstream cannabis member-cultivators and downstream member-buyers. Leveraging thousands of data points, Thrive Society empowers farmers to sell cannabis in bulk to buyers with confidence that the market value for their product is competitive – providing a much-needed solution to the marketplace’s existing inconsistent pricing structure. Thrive Society members receive priceless insight into harvesting and demand trends, allowing growers to forecast cultivation strategies in real time. For buyers, Thrive Society offers a real-time marketplace of an extensive library of wholesale cannabis available for sale throughout the state, eliminating stock-out issues and increasing price transparency.

 

“In every industry, data is king,” said Devin Calloway, co-CEO, Founder and CTO of Eco Farm. “So many operators are flying blind when it comes to harvest planning, price forecasting and inventory management. Our platform, which is fueled by actual transaction metrics that are occurring in real time, offers both sellers and buyers the invaluable information they need to make data-driven operational decisions, mitigate risk and increase profit margins.”

 

With two showrooms in Los Angeles and Santa Rosa, Thrive Society members are able to list their cannabis products for sale. Showcased products can range from dried flower to concentrates, including product test results, batch information on the product and its availability, and users can post a fair and transparent price, something not seen in most distribution models currently employed throughout the industry. Thrive Society operates under a community membership model where support of mutually beneficial transactions is core to the Company’s ethos.

 

“Many cannabis businesses still rely on antiquated supply chain systems. Leveraging our years of experience in the cannabis industry, we have built a tech-forward infrastructure model throughout California’s cannabis supply chain that allows us to operate in an efficient and transparent way,” said Danielle Dao, co-CEO and Founder of Eco Farm. “Achieving this milestone of supporting over 600 cannabis operators in the world’s largest cannabis market is a true illustration of the potential national success of our model, which is powered by technology.”

 

While Thrive Society is one of the largest revenue-generating and innovative segments of the Company, Eco Farm is a portfolio of holdings comprised of operating assets in genetics, cultivation, manufacturing, and consumer brands. Through the Company’s licensed nursery facility and relationships with preferred nursery partners, the Company offers hundreds of genetic varieties of popular cultivars with unparalleled consistency. Genetics remain one of the most important pieces of the cannabis supply chain and leveraging this integrated approach allows Eco Farm to own and control one of the most volatile pieces of the supply chain.

 

Eco Farm’s highly successful cannabis consumer brand, Lifted Legacy, supports family-owned craft farms in the Emerald Triangle and brings high-quality cannabis cultivars to market. The  Lifted Legacy brand is sold in over 75 retail shops throughout California and offers products that are region-specific and chosen through data provided by the Thrive Society platform. Rounding out the vertical integration of Eco Farm is the Company’s highly scalable manufacturing facility, where the Company processes cannabis products for its own brands as well as countless brands sold throughout the state. The entire portfolio is powered by Eco Farm’s world-class technology and plant-touching platforms, including Thrive Society, which is uniquely positioned as a scalable model for emerging markets across the country.

 

Eco Farm is a public benefit corporation, meaning the Company considers additional stakeholders in its decision-making process besides the traditional economic benefit of its shareholders. Stakeholders could include the community in which the Company operates, the environment as it is impacted by the operations of the business, or its staff and the overall benefit of their involvement in the organization. While this designation adds an additional layer of complexity to the Company’s operations, it was chosen as a way to add tangible metrics to the Company’s mission of driving change through intent and action. The Company is led and staffed by people from all backgrounds and constantly supports social equity programs throughout the industry. 

 

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, announced that it has entered into a partnership with an established Argentine pharmaceutical company to register and commercialize Avicanna’s proprietary cannabinoid-based pharmaceutical preparations through the licensing of its intellectual property and supply of its active pharmaceutical ingredients (“API”).

 

Through the partnership Avicanna will provide a non-exclusive license of the Company’s intellectual property related to its proprietary 10% cannabidiol (“CBD”) pharmaceutical drug preparation. Additionally, the partner will source its pharmaceutical-grade CBD exclusively from Avicanna to manufacture the product for the registration and marketing authorization with the Argentine regulatory agency ANMAT.

 

The marketing authorization of the pharmaceutical preparation is expected to be approved during the second half of 2022 and is expected to be supported with claims related to treatment of epilepsy. The estimated patient population and market potential for epilepsy in Argentina is between 400,000 to 500,000 patients of which about 20,000 patients have refractory epilepsy. “We look forward to entering the Argentine market through a pharmaceutical pathway and to be doing so by delivering our proprietary formulations as solution to patients with unmet medical needs. We are rapidly expanding into the region with innovative and accessible cannabinoid-based pharmaceutical products and are doing so through partnership with reputable industry leaders,” stated Lucas Nosiglia, President of Avicanna LATAM.

 

Love Pharma Inc. (CSE: LUV) ,a Vancouver, Canada-based company, which operates as a specialized health and wellness company that licenses and distributes psychedelic and cannabis-infused products, has established a practice of offering proven products with clinical data, user studies, and scientific research to support its claims.  It’s a practice that gives Love Pharma a distinct market advantage over many of its competitors.  And now, Love Pharma is set to broaden that advantage with its recent announcement that the company has signed a Letter of Intent to acquire MicroDoz Therapy, Inc. 

 

The benefit of this acquisition to Love Pharma, its shareholders and worldwide consumers is that the company gains MicroDoz’s exclusive partnership with a world-renowned university to conduct a landmark study into the efficacy of psilocybin assisted treatment of cannabis use disorder.  Love Pharma can leverage this relationship to further expand its product lineup, strengthen its clinical validation program, and add to its comprehensive portfolio of intellectual property.

 

Specifically, the acquisition will further substantiate the company’s efforts to become a frontrunner in the psychedelics and therapeutics space.  Love Pharma’s Chief Executive Officer (CEO), Zach Stadnyk, said his company’s existing portfolio, which consists of the exclusive rights to 7 novel therapeutic products focused on mental and sexual wellness, is already at the leading edge of innovation in the industry.  So, continued new product development will further build upon what is already a strong foundation.  Stadnyk’s goal is to establish a growing and loyal customer base as the company seeks to define the psychedelics and therapeutics industry with solid science that leads to effective products.

When explaining the acquisition of MicroDoz Therapy, the CEO stated, “Science and efficacy are paramount to our strategy, as a result we seized the opportunity to acquire MicroDoz to expedite what will be a landmark study with a world-leading university.”

 

As an entry point into the burgeoning psychedelics market, the company acquired the rights to the patent-pending psilocybin strip in addition to the acquisition of MicroDoz, which has the exclusive partnership to the landmark study at an unnamed leading global university.  Love Pharma announced it expects to release the university’s name along with details of the program when the definitive agreement is close.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com

 podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Podcasts and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news,  third party stock research , guest posts and original  articles and podcasts in leading stock sectors.  Learn about investing in stocks and get  investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.     

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Tuesday, 16 November 2021

Investor Ideas #Potcasts 613, #Cannabis News and #Stocks on the Move; CEO of Medical Marijuana, Inc. (OTC: $MJNA)

 



Investor Ideas #Potcasts 613, #Cannabis News and #Stocks on the Move; CEO of Medical Marijuana, Inc. (OTC: $MJNA)

 

Delta, Kelowna, BC, November 16, 2021 (Investorideas.com Newswire) www.Investoride, as.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/111621-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/11161Interview-MJNA.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast Investorideas interviews Blake Schroeder, Esq, CEO of Medical Marijuana, Inc. (OTC: MJNA) where we discussed the recent announcement from JPMorgan Chase & Co. that the company will no longer allow the purchase of stocks in some U.S. cannabis companies that have a “direct nexus to marijuana-related activities” and are not listed on the Nasdaq, the New York Stock Exchange or the Toronto Stock Exchange, how this affects the industry as well as how this impacts MJNA.

 

Blake Schroeder recently commented on the news, saying, "The longer we prolong federal cannabis legislation, the more financial institutions we will see making similar statements as JPMorgan. As the first-ever cannabis company to become publicly traded in the US, as well as on OTC Markets, we've witnessed the many ups and downs of cannabis stocks over the years and have been pleasantly surprised that cannabis has been one of the few industries to come out of the pandemic even stronger than before. We’ve seen positive movement for the industry on both the federal level, with the passage of the 2018 Farm Bill, and many state levels, including the recent passage of California AB 45. We hope that financial institutions and regulators see clearly the positive movement that is happening around the world and, instead of making decisions like this that do more harm than help in keeping people safe from fraud, positively align. We will continue to fight for fair access to financial services for as long as it takes.”

 

Shroeder went on to discuss MJNA’s international strategies in Finland, Japan and Hin Kong commenting, “Finland, I believe it was three years ago, was giving us a hard time saying that CBD wasn’t legal in their country. A lot of companies would just back down but not us, we filed lawsuits for “Free Access” and we fought and we won. Free Access is incredibly important to us, and if you’ve met some of the families that I’ve met and you’ve seen how their lives have changed because they can have free access to cannabis, whether it's psychoactive or non-psychoactive. We want to be the world’s first truly global cannabis company so we recently launched in Hong Kong. A few years ago we launched non-psychoactive products into the country of Japan and have had incredible growth there. Hong Kong is really an entryway to the Chinese speaking market all over the world, which is the largest market in the world. We think there’s great things coming in the far East.”

 

The legal “win” Shroeder refers to is when MJNA announced back in October that the Company’s subsidiary Kannaway® had won a historic court case in Finland proving the legality of the importation of the Company’s cannabidiol (CBD) oil.

 

“We have been a leader in bringing CBD to Finland, as well as to many other countries across Europe,” said Kannaway® CEO Blake Schroeder. “We knew that our operations and sales were legal in Finland but receiving this ruling from the Finnish High Supreme Administrative Court is promising for the future of our company and the entire industry. We are well on our way to becoming the first truly global cannabis company in the world.”

 

In 2018, Finnish Customs confiscated a bottle of Kannaway® Pure Gold and claimed that it was illegally imported since FIMEA, the Finnish Medicines Agency, lists CBD as a medicinal ingredient, causing the Finnish Customs Authority to take a “blanket approach” in treating all CBD products like medicines. On Friday, October 22, 2021, the Finnish Supreme Administrative Court declared that any product, according to EU directives, would need to be classified as a medicinal product on a case-by-case basis with specific claims on therapeutic effects, dosage and supporting evidence. In this case, the Supreme Administrative Court has declared that Kannaway® Pure Gold hemp oil is not a medicinal product.

 

Shroeder went on to discuss the different quality levels within the CBD space both internationally and domestically in the US, the difference between medicinal and wellness products as well as some of the positive movement being noticed within the industry at the moment, despite some negative press surrounding federal reform issues.

 

To find out more about Medical Marijuana Inc. visit their website here.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

To hear more Investorideas.com

 podcasts visit: https://www.investorideas.com/Audio/.

 

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Podcasts and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news,  third party stock research , guest posts and original  articles and podcasts in leading stock sectors.  Learn about investing in stocks and get  investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.     

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock direct

Monday, 15 November 2021

Psychedelic Stock News: Red Light Holland (CSE: TRIP) Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory

Psychedelic Stock News: Red Light Holland (CSE: TRIP) Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory

Investor Ideas #Potcasts 612, #Cannabis News and #Stocks on the Move; Interview with Founder and Lead Pastor of Pachamama Ayahuasca Sanctuary

 



Investor Ideas #Potcasts 612, #Cannabis News and #Stocks on the Move; Interview with Founder and Lead Pastor of Pachamama Ayahuasca Sanctuary

 

Delta, Kelowna, BC, November 15, 2021 (Investorideas.com Newswire) www.Investoride, as.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/111521-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/11151Interview-Pachamama-Sanctuary.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast Investorideas interviews Derek Januszewski, the founder and Lead Pastor at Pachamama Sanctuary, where we discussed his personal journey with Ayahuasca as well as how Pachama Sanctuary helps heal patients today. 

 

Derek is a survivor of tremendous abuse in many forms and came to the medicine in 2017 after a decade-long battle with addiction. Through intense inner work, extensive work with medicine, and countless hours working in service,

 

On his first Ayahuasca experience Januszewski commented, “I was at a really dark point in my life. I was suffering with addiction and I wanted to quit so badly and I was going to AA a lot. I was doing multiple 90 day meetings in 90 day runs, and was really putting in the work and wasn’t getting any relief and I really wanted to quit. I was listening to Joe Rogan’s podcast and he talked about the healing powers of Ayahuasca, and I thought alright I’m willing to try anything, I’m desperate.  I was going to go to Peru and then my son found a place in Orlando. So I went to Orlando and sat with the medicine for the first time with my intention being to relieve me of my resentment towards my father and to release some of the compulsion I had to use and get high. My first ceremony wasn’t super intense but it was very eye opening. At one point I went to the mirror and saw this demon staring back at me, and \I wasn’t scared, but I didn’t want it there any more. I knew it was driving everything. The next day at integration, where we circle up and talk about our experience, I started talking about what it was because I see both my face and my father’s face in this demon staring back at me. I started to cry uncontrollably, and that’s something I wasn’t able to do at all. I wanted to cry, I could feel all these tears in me that just were not coming out, and then they all came out. I had a conversation with somebody at the Church down there and he helped me see some of the things that I got from the relationship from my father. On my second night, I drank the medicine, and I really didn’t want to go to the mirror. Then I felt the purge rumble up in me and when I released it, I heard this voice that said (Go meet your father!) which I knew meant I had to go to the mirror again. When I went to the mirror I saw something completely different. There were beams of light coming down on me and a beautiful face with tears coming down with joy and I loved what I saw in the mirror and I said that. I said (I love you! I love you!) to the mirror. Before that I hadn’t talked to my father in more than 4 years, and  after that a couple weeks later I was back having conversations with my father and we had picked up our relationship on a really positive note and my compulsion to use was gone for a while. Now I had a lot of trauma to dig into and I had some relapses but the road to recovery started that day.”

 

Pachamama Sanctuary is an ayahuasca center, located in Southern New Hampshire and was founded in 2019. Since its inception, their mission has been to raise collective consciousness through the sacrament, Ayahuasca. Ayahuasca is a tea derived from plants from the Amazon rainforest and has helped people gain insight and provide clarity into past traumas and provides a chance to find peace resulting from addiction, PTSD or negative cycles.

 

When asked about maintaining the spiritual integrity of the plant and keeping this knowledge within indigenous hands Derek commented, “As far as keeping the medicine in the hands of the indegenous and all of that, there’s a lot of conflict in those ideas. Most of the people who express those ideas have not been to South America and have not talked to Shamans. They've read stuff online, developed their own ideas about what appropriation is and decided that I’m appropriating or that other people are appropriating. When I have Shamans and Taitas and Ayahuasqueros that come here, they really appreciate what we are doing. I provide a space for them to be able to come and do their work and they love it and they honour what we’re doing. They want to see more of it because the Western World, kind of lead by America, is doing a lot to separate people and poison minds and poison bodies. If we can fix the mindset of America, that’s going to do a tremendous amount to unite and settle the world. They want it to come here. This medicine is coming out of the shadows after thousands of years in this point in time and in America for a reason. Terrance McKenna said (The Plant’s are talking to us, this is not a metaphor) so I think we should listen.”

 

Derek went on to discuss his journey from Ayahuasca patient to Lead Pastor of his own Ayahuasca Sanctuary and how he has begun to trust the medicine and the plants to be his guide through many personal experiences and continued coincidences.

 

To find out more information on Pachama Sanctuary visit their website: https://www.pachamamaretreats.org/

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com

 podcasts visit: https://www.investorideas.com/Audio/.

 

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Podcasts and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news,  third party stock research , guest posts and original  articles and podcasts in leading stock sectors.  Learn about investing in stocks and get  investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.     

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Cannabis Stock News: Nextleaf (CSE: OILS) Awarded Jamaican Patent for its Foundational Extraction Process

Cannabis Stock News: Nextleaf (CSE: OILS) Awarded Jamaican Patent for its Foundational Extraction Process